Skip to main content

Table 2 Clinical characteristics of control subjects

From: A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis

Control number

Age/gender

Cause of the death

AHT

Diabetes

Dyslipidemia

1

64/M

Bronchopneumonia

No

No

No

2

51/F

Septic shock

Yes

No

No

3

47/H

Sepsis

No

No

No

4

47/F

Bacterial pneumonia

No

No

No

5

47/F

Carcinogenesis

No

No

No

6

34/M

Acute Pancreatitis

Yes

No

No

7

64/F

Bacterial Sepsis

No

No

No

8

78/F

Bronchopneumonia

No

No

No

9

42/F

Lymphoma

No

No

No

10

67/M

Renal insufficiency

No

No

No

11

74/M

COPD

No

No

No

12

87/F

Carcinoma

No

No

No

13

48/F

Pulmonary thromboembolism

No

No

No

14

55/M

Pneumonia

No

No

No

15

87/F

Cholelithiasis

No

No

No

16

76/M

Carcinoma

No

No

No

17

80/F

Atrial fibrillation

Yes

Yes

No

18

49/F

Respiratory insufficiency

No

No

No

19

74/M

Septic shock

Yes

No

Yes

20

77/F

COPD

Yes

No

No

Mean

69 ± 7.07/40% M–60% F

 

25.00%

5%

5%

  1. F female, M male, AHT arterial hypertension, COPD chronic obstructive pulmonary disease